Clinical Trial Update: Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer

View source ↗

Summary

This clinical trial update indicates ongoing recruitment for an exploratory biomarker analysis of neoadjuvant chemoimmunotherapy followed by surgical resection …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Yonsei University | Conditions: Clinical Stage II to III Non-Small Cell Lung Cancer | Status: RECRUITING